Bay Street News, 2018

ADVM-022 is the first intravitreally delivered gene therapy utilizing directed evolution AAV.7m8 vector for wet AMD OPTIC trial to evaluate […]

MILTON, GA , Nov. 19, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Attis Industries Inc. (NASDAQ: ATIS) (the “Company” or […]

CALGARY, Alberta, Nov. 19, 2018 (GLOBE NEWSWIRE) — Bengal Energy Ltd. (TSX: BNG) (“Bengal” or the “Company”) announces that it […]

VANCOUVER, British Columbia, Nov. 19, 2018 (GLOBE NEWSWIRE) — Otis Gold Corp. (“Otis” or the “Company”) (TSX-V: OOO) advises that […]

Updates Value of the Market Opportunity in Existing Applications from $2.2 Billion to $2.7 Billion Announces Market Development and Clinical […]

DENVER and CHICAGO, Nov. 19, 2018 (GLOBE NEWSWIRE) — The American Diabetes Association along with Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) […]

Sponsorship includes a pre-course meeting in addition to four workshops on a variety of topics WARSAW, Ind., Nov. 19, 2018 […]

TORONTO, Nov. 19, 2018 (GLOBE NEWSWIRE) — Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to […]

TORONTO, Nov. 19, 2018 (GLOBE NEWSWIRE) — Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) is pleased to announce the […]

VANCOUVER, British Columbia, Nov. 19, 2018 (GLOBE NEWSWIRE) — Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) (the “Company” […]